PROS1 and COVID-19: However, the involvement of FGFR3 antibodies indicates binding of the RBD of viral S protein with FGFR3 receptors, but with lower affinity than ACE2 receptors, which can cause an immunological response leading to inflammation and an associated SFN post-COVID-19 vaccination [135,214].